Clues to curing Aids could live in antibodies

The discovery of how a KwaZulu-Natal woman's body responded to her HIV infection by making potent antibodies may hold the clue to an HIV vaccine or cure for Aids.

In a study that was published in the scientific journal, Nature, on Sunday night, South African and American researchers describe how the research team found and identified these antibodies in her blood, and then duplicated them by cloning the antibodies in a laboratory. The cloned antibodies were used in a series of experiments to elucidate the pathway followed by her immune system to make the antibodies.

The antibodies of the woman, who is referred to as Caprisa 256 in the study, were analysed from six to 225 weeks after infection. "These potent antibodies take years to develop as antibodies constantly evolve. We discovered Caprisa 256's potent antibodies three years after she got infected, so we went backwards in time and traced how they changed over time," said co-author Salim Abdool Karim, who is head of the Centre for the Aids Programme of Research in South Africa (Caprisa).

All HIV infected people respond to the virus by making antibodies. In most patients, these antibodies are not able to kill HIV. However, the immune systems of a few infected people naturally produces antibodies that kill, or neutralise, a wide range of HIV. Such antibodies are called broadly neutralising antibodies.


Virus changes
"Broadly neutralising antibodies have some unusual features. The outer covering, or envelope, of HIV has a coating of sugars that prevents antibodies from reaching the surface to neutralise the virus," said Penny Moore, one of the lead South African scientists on the study based at the National Institute of Communicable Diseases. "In this patient, we found that her antibodies had 'long arms', which enabled them to reach through the sugar coat that protects HIV. We discovered that the antibodies had 'long arms' right at the outset, requiring less time and fewer changes to become effective in killing HIV."

Ironically, Caprisa 256 is on antiretroviral treatment, as her antibodies are unable to kill the HIV in her own body. "When a person develops broadly neutralising antibodies it actually has no benefit to the individual who develops it; [they are] not able to neutralise their own virus," said Abdool Karim. "The reason for that is that it takes several weeks for the antibodies to develop while the virus continues to constantly change. By the time the antibodies become available, they're no longer working for the HIV that exists in the person's body at that time."

Karim said HIV is unusual in the sense that antibodies co-exist with the virus in an infected person's body. "When someone has antibodies against measles, it means they've overcome measles and that their antibodies have destroyed the measles virus. But that is not the case with HIV, as the virus mutates and changes so rapidly." 

The identification and successful cloning of Caprisa 256's antibodies enables the researchers to make sufficiently large quantities for further testing, similar to the way a medicine used to prevent or treat HIV would be tested. "Our goal is to test these antibodies, preferably in combination with other broadly neutralising antibodies, directly in patients with HIV infection or in those at risk of getting infected," says Karim.

"But this will take some time as the team is currently planning animal studies as a first step. Broadly neutralising antibodies have previously been shown to be effective in preventing and treating HIV infection in animals, but this has never before been shown in humans." 

'Bring an end to Aids'
South African researchers who worked on the study under the umbrella of the "Caprisa consortium" include scientists from the National Institute for Communicable Diseases in Johannesburg, as well as the University of KwaZulu-Natal and University of Cape Town. United States-based partners include Columbia University in New York and the Vaccine Research Centre at the National Institute of Allergy and Infectious Diseases.

Health Minister Aaron Motsoaledi was excited about the research under Abdool-Karim's leadership. "Since South Africa has the largest burden of HIV infection globally, we are gratified to see South African scientists undertake this research to find solutions that will bring an end to Aids. We are hopeful that this research will take us one step closer to developing an Aids vaccine," he said.

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Mia Malan
Mia Malan
Mia Malan is the founding director and editor of the Bhekisisa Centre for Health Journalism at the Mail & Guardian. She heads up a team of fifteen permanent and freelance staff members. She loves drama, good wine and strong coffee, not necessarily in that order.
Bhekisisa team
Bhekisisa Team
Health features and news from across Africa by Bhekisisa, the Mail & Guardian's health journalism centre.

Related stories

How US foreign policy under Donald Trump has affected Africa

Lesotho has been used as a microcosm in this article to reflect how the foreign policy has affected Africa

From ‘academic boys’ to ‘sex-jaros’: What it means to be a black boy in a South African township

Toxic masculinities help drive everything from HIV infection rates to gender-based violence. But before we ask, what does it mean to be a ‘man’ in South Africa, should we wonder what it’s like to be a boy?

Eusebius McKaiser: A witness to Covid-19 stigma

Let us please not repeat the devastating Aids story where people died of shame rather than admit being infected by the virus

Three months in, Covid-19 poses triple threats in Africa

Health, debt and hunger are huge threats to the continent’s stability

Bail could be the key to reducing severe prison overcrowding

More than a quarter of prisoners have not been convicted of anything, they just couldn’t meet bail requirements

In a pandemic, science and humanities work side by side

Anthropologists ask the difficult questions about human behaviour and also provide the difficult answers
Advertising

Subscribers only

SAA bailout raises more questions

As the government continues to grapple with the troubles facing the airline, it would do well to keep on eye on the impending Denel implosion

ANC’s rogue deployees revealed

Despite 6 300 ANC cadres working in government, the party’s integrity committee has done little to deal with its accused members

More top stories

Fake trafficking news targets migrants

Exaggerated reports on social media of human trafficking syndicates snatching people in broad daylight legitimate xenophobia while deflecting from the real problems in society

It’s not a ‘second wave’: Covid resurges because safety measures...

A simple model shows how complacency in South Africa will cause the number of infections to go on an upward trend again

Unisa shortlists two candidates for the vice-chancellor job

The outgoing vice-chancellor’s term has been extended to April to allow for a smooth hand-over

How US foreign policy under Donald Trump has affected Africa

Lesotho has been used as a microcosm in this article to reflect how the foreign policy has affected Africa
Advertising

press releases

Loading latest Press Releases…

The best local and international journalism

handpicked and in your inbox every weekday